Copyright 2019 Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Thursday reported a loss of $33.8 million in its second quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 91 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.
The biotechnology company posted revenue of $16.6 million in the period.
Regenxbio shares have decreased 16% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $34.30, a decline of 17% in the last 12 months.
Insight by Tanium: A new Federal News Network survey reports that IT and cyber executives say technology risk management is a balancing act of cybersecurity, mission and personnel.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX
Copyright © 2020 . All rights reserved. This website is not intended for users located within the European Economic Area.